Fig. 2From: Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scansCT and SPECT/CT coronal views of patient no. 11, 7b, and 6 showing the distribution of 188Re-HDD-Lipiodol in liver tissue at 3Â h after administration of the radiopharmaceuticalBack to article page